Systems-level computational modeling in ischemic stroke: from cells to patients

• Published in: Frontiers in physiology 2024-07, Vol.15, p.1394740
• Main Authors: Li, Geli, Zhao, Yanyong, Ma, Wen, Gao, Yuan, Zhao, Chen
• Format: Article
• Language: English
• Subjects: computational modeling; ischemic stroke; network pharmacology; Physiology; system biology; virtual clinical trial
• ISSN: 1664-042X; 1664-042X
• DOI: 10.3389/fphys.2024.1394740

Ischemic stroke, a significant threat to human life and health, refers to a class of conditions where brain tissue damage is induced following decreased cerebral blood flow. The incidence of ischemic stroke has been steadily increasing globally, and its disease mechanisms are highly complex and involve a multitude of biological mechanisms at various scales from genes all the way to the human body system that can affect the stroke onset, progression, treatment, and prognosis. To complement conventional experimental research methods, computational systems biology modeling can integrate and describe the pathogenic mechanisms of ischemic stroke across multiple biological scales and help identify emergent modulatory principles that drive disease progression and recovery. In addition, by running virtual experiments and trials in computers, these models can efficiently predict and evaluate outcomes of different treatment methods and thereby assist clinical decision-making. In this review, we summarize the current research and application of systems-level computational modeling in the field of ischemic stroke from the multiscale mechanism-based, physics-based and omics-based perspectives and discuss how modeling-driven research frameworks can deliver insights for future stroke research and drug development.